Canopy Growth Corporation has successfully secured a renewal of its EU GMP (Good Manufacturing Practice) certification for its production facility in Kincardine, Ontario, marking a vital operational victory as the company pivots to capture a larger share of the expanding European medical cannabis market. This regulatory validation ensures the facility remains compliant with the stringent…
Curaleaf Holdings Inc. has officially circumvented the executive leadership at Aurora Cannabis, initiating a direct hostile takeover bid to shareholders following repeated refusals from Aurora’s board of directors to engage in formal buyout discussions. This aggressive maneuver forces a direct confrontation between the institutional ambitions of Curaleaf and the defensive posture of the Aurora leadership,…
As the legal cannabis market matures across the United States, a new qualitative study from the Parabola Center has exposed a complex emotional landscape among consumers. While the normalization of the industry has successfully reduced the risks associated with the illicit market, users in nine surveyed states are increasingly vocal about two critical pain points:…
New surveillance data from the Centers for Disease Control and Prevention (CDC) has brought a previously obscured medical issue into the spotlight: a significant, documented rise in hospital visits related to severe, recurrent nausea and vomiting among frequent marijuana users. While the headlines may suggest a sudden epidemic, public health experts emphasize that this surge…
Senator Ted Budd (R-NC) has ignited a pivotal debate on Capitol Hill, introducing an amendment to a critical Senate spending bill that would effectively restrict the sale of intoxicating hemp-derived THC products. This legislative maneuver, if successful, would tighten federal regulations by November, aiming to close the controversial ‘loophole’ created by the 2018 Farm Bill…
Alabama’s recent formal objection to the Trump administration’s federal medical marijuana rescheduling initiative has ignited a constitutional standoff that threatens to complicate the state’s nascent medical cannabis market. As federal authorities weigh the monumental shift of cannabis from a Schedule I to a Schedule III controlled substance, Alabama Attorney General Steve Marshall’s resistance has thrust…
Effective July 31, 2026, the Texas Department of State Health Services (DSHS) has fundamentally altered the commercial landscape for retailers and consumers by reinstating controlled-substance definitions that effectively reclassify Delta-8 THC and other non-Delta-9 THC isomers. This regulatory pivot, triggered by a pivotal Texas Supreme Court ruling, marks a significant departure from the permissive atmosphere…
A landmark shift in American consumption habits has been officially confirmed as daily cannabis use has surpassed both daily alcohol and cigarette consumption, according to recent analysis of data provided by the Substance Abuse and Mental Health Services Administration (SAMHSA). This historic reversal indicates that for the first time in modern history, marijuana has become…
Vireo Growth Inc. has officially entered into a definitive merger agreement to acquire Planet 13 Holdings Inc., marking a pivotal consolidation move within the multi-state cannabis sector. The acquisition, which involves Vireo acquiring all outstanding equity interests of Planet 13, represents a significant recalibration for both companies as they seek to navigate an increasingly complex…
Senator John Fetterman has issued a direct challenge to the United States Congress, demanding immediate action to dismantle the outdated federal prohibition of cannabis. In a series of high-profile appeals, the Pennsylvania Democrat is championing a legislative framework that moves beyond mere decriminalization, advocating for a full descheduling of cannabis and its regulation, modeled after…
